Fig. 4. Cash flow after donor management. HLA, human leukocyte antigen; KODA, Korea Organ Donation Agency.

Korean J Transplant 2019;33:83~97 https://doi.org/10.4285/jkstn.2019.33.4.83

© Korean Journal of Transplantation